|
USA-2741-Publishers कंपनी निर्देशिकाएँ
|
कंपनी समाचार :
- What are the new drugs for plaque psoriasis?
Another new treatment for plaque psoriasis is the tyrosine kinase 2 (TYK2) inhibitor deucravacitinib (Sotyktu) TYK2 inhibitors work by inhibiting TYK2, an intracellular signaling kinase that mediates signaling of IL-23, IL-12 and Type I IFN, which are naturally occurring cytokines involved in inflammatory and immune responses
- Psoriasis 101: Causes, Symptoms and Treatments, Explained
Psoriasis is a lifelong condition, but with the right care, most people can manage their symptoms and live comfortably Understanding your type of psoriasis, identifying triggers and following your treatment plan can make a big difference
- List of 79 Plaque Psoriasis Medications Compared - Drugs. com
Plaque psoriasis (psoriasis vulgaris) is the most common form of psoriasis and treatment options include topical therapy, light therapy, and oral or injected medications Topical treatments for plaque psoriasis include: Corticosteroids: These are frequently prescribed for mild to moderate plaque psoriasis and are available as oils, ointments, creams, lotions, gels, foams, sprays, and shampoos
- Dupixent: Uses, Dosage, Side Effects, Warnings - Drugs. com
Dupixent is used to treat multiple inflammatory conditions, including moderate-to-severe eczema (atopic dermatitis), eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), chronic spontaneous urticaria, prurigo nodularis, or bullous pemphigoid This self-administered subcutaneous
- Skyrizi: Uses, Dosage, Side Effects and more Drugs. com
Skyrizi (risankizumab) is an injection used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease Includes indications, doses, interactions, side effects and more
- Psoriasis Guide: Causes, Symptoms and Treatment Options
Psoriasis - an easy to understand guide covering causes, diagnosis, symptoms, treatment and prevention plus additional in depth medical information
- Johnson Johnson Seeks First Icotrokinra U. S. FDA Approval Aiming to . . .
Johnson Johnson Seeks First Icotrokinra U S FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
- Psoriatic arthritis Guide: Causes, Symptoms and Treatment Options
Treatment Prognosis What is Psoriatic arthritis? Psoriatic arthritis is a chronic (long-lasting) disease in which a person with psoriasis develops the symptoms and signs of arthritis, including joint pain, stiffness and swelling Psoriasis is a common, inherited skin condition that causes grayish-white scaling over a pink or dull-red skin rash
- Arcutis’ Zoryve (roflumilast) Topical Foam 0. 3% Approved by U. S. FDA . . .
Roflumilast cream 0 3% (Zoryve ®) is approved by the FDA for the topical treatment of plaque psoriasis, including intertriginous areas, in patients 6 years of age and older Roflumilast cream 0 15% (Zoryve ®) is approved by the FDA for the topical treatment of mild to moderate atopic dermatitis in patients 6 years of age and older
- Tremfya Patient Tips: 7 things you should know - Drugs. com
IL-23 is thought to be crucial in regulating inflammation that stems from infection or chronic autoimmune conditions, such as psoriasis, inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis
|
|